Work

CDK4/6 Inhibition as a therapeutic strategy in breast cancer: palbociclib, ribociclib, and abemaciclib

Year: 2017

Type: article

Source: Seminars in Oncology

DOI: 10.1053/j.seminoncol.2018.03.006

Authors: Bahar Laderian, Tito Fojo

Institutions: Columbia University Irving Medical Center, James J. Peters VA Medical Center

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2793671087

FWCI: 3.314

Cites: 17

Cited by: 77

Related to: 10